The renal consequences of arterial hypertension

被引:35
作者
Mountokalakis, TD
Madias, NE
Harrington, JT
Rennke, HG
Vosnides, G
Symvoulidou, D
Grekas, D
Emmanouel, DS
Christidou, F
Lasaridis, A
Boletis, J
Stefanidis, C
Tsakiris, D
机构
[1] TUFTS UNIV NEW ENGLAND MED CTR, DIV NEPHROL, BOSTON, MA 02111 USA
[2] TUFTS UNIV, SCH MED, BOSTON, MA 02111 USA
[3] BRIGHAM & WOMENS HOSP, RENAL PATHOL & ELECT MICROSCOPY LAB, BOSTON, MA 02115 USA
[4] LAIKON GEN HOSP, ATHENS, GREECE
[5] HIPPOKRATION HOSP, ATHENS, GREECE
[6] AHEPA UNIV HOSP, THESSALONIKI, GREECE
[7] UNIV CRETE, SCH MED, IRAKLION, GREECE
[8] IKA GEN HOSP 2, THESSALONIKI, GREECE
[9] KYRIAKOU CHILDRENS HOSP, ATHENS, GREECE
[10] HIPPOKRATEION HOSP, THESSALONIKI, GREECE
[11] UNIV ATHENS, SCH MED, GR-11527 ATHENS, GREECE
关键词
D O I
10.1038/ki.1997.226
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1639 / 1653
页数:15
相关论文
共 109 条
[1]   NIFEDIPINE VERSUS FOSINOPRIL IN UNINEPHRECTOMIZED DIABETIC RATS [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM ;
ZAYAS, MA ;
LAFFERTY, HM ;
TROY, JL ;
SANDSTROM, DJ .
KIDNEY INTERNATIONAL, 1992, 41 (04) :891-897
[2]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[3]   SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE THERAPY IN THE DIABETIC RAT [J].
ANDERSON, S ;
RENNKE, HG ;
GARCIA, DL ;
BRENNER, BM .
KIDNEY INTERNATIONAL, 1989, 36 (04) :526-536
[4]  
[Anonymous], 1991, JAMA, V265, P3255
[5]  
[Anonymous], 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.213.7.1143
[6]  
BABA T, 1989, DIABETOLOGIA, V32, P40
[7]   TREATMENT OF ARTERIAL-HYPERTENSION IN DIABETIC HUMANS - IMPORTANCE OF THERAPEUTIC SELECTION [J].
BAKRIS, GL ;
BARNHILL, BW ;
SADLER, R .
KIDNEY INTERNATIONAL, 1992, 41 (04) :912-919
[8]  
Bauer J H, 1995, Curr Opin Nephrol Hypertens, V4, P427, DOI 10.1097/00041552-199509000-00010
[9]   A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF ENALAPRIL IN PATIENTS WITH CLINICAL DIABETIC NEPHROPATHY [J].
BAUER, JH ;
REAMS, GP ;
HEWETT, J ;
KLACHKO, D ;
MESSINA, C ;
KNAUS, V .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (05) :443-457
[10]   EFFECTS OF PRAZOSIN THERAPY ON BP, RENAL-FUNCTION, AND BODY-FLUID COMPOSITION [J].
BAUER, JH ;
JONES, LB ;
GADDY, P .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (06) :1196-1200